Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | mRNA-4157 |
Trade Name | |
Synonyms | mRNA4157|mRNA 4157|V940|V-940|V 940 |
Drug Descriptions |
mRNA-4157 is an mRNA-based lipid encapsulated personalized cancer vaccine encoding specific neoantigens, which potentially leads to enhanced anti-tumor immune response (Journal for ImmunoTherapy of Cancer 2020;8). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C146813 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
mRNA-4157 | mRNA-4157 | 0 | 1 |
mRNA-4157 + Pembrolizumab | Pembrolizumab mRNA-4157 | 0 | 7 |